Browsing by Author "Ecevit, A."

Now showing 1 - 7 of 7

Approach to hypoglycemia in the newborn: Turkish neonatal and pediatric endocrinology and diabetes societies consensus report
(2018) Aiefendioğlu, D.; Çoban, A.; Hatipoğlu, N.; Ecevit, A.; Arısoy, A.E.; Yeşiltepe, G.; Baş, F.; Bideci, A.; Özek, E.
Hypoglycemia is one of the most important and most common metabolic problems of the newborn because it poses a risk of neurological injury, if it is prolonged and recurs. Therefore, newborns who carry a risk of hypoglycemia should be fed immediately after delivery and the blood glucose level should be measured with intervals of 2-3 hours from the 30th minute after feeding. The threshold value for hypoglycemia is 40 mg/dL for the first 24 hours in symptomatic babies. In asymptomatic babies, this value is considered 25 mg/dL for 0-4 hours, 35 mg/dl for 4-24 hours, 50 mg/dL after 24 hours and 60 mg/dL after 48 hours. Screening should be performed with bed-side test sticks. When values near the limit value are obtained, confirmation with laboratory method should be done and treatment should be initiated, if necessary. The level targeted with treatment is considered 50 mg/dL in the postnatal first 48 hours before feeding, 60 mg/dL after 48 hours in babies with high risk and above 70 mg/dL in babies with permanent hypoglycemia. In cases in which the blood glucose level is below the threshold value and can not be increased by feeding, a glucose infusion of 6-8 mg/kg/min should be initiated. If symptoms accompany, a mini bolus of 10% dextrose (2 ml/kg/min) should accompany. Incements (2 mg/kg/min) should be performed, if the target level can not be achieved and decrements (2 ml/kg/ min) should be performed, if nutrition and stabilization is provided. The infusion should be discontinued, if the infusion rate decreases to 3-5 mg/ kg/min. If necessary, blood samples should be obtained during hypoglycemia in terms of differential diagnosis and the investigation should be performed following a 6-hour fasting period in babies fed enterally and at any time when the plasma glucose is <50 mg/dL in babies receiving parenteral infusion. The hypoglycemic babies in the risk group whose infusions have been terminated can be discharged, if the plasma glucose level is found to be at the target level for two times before feeding and babies with permanent, severe or resistant hypoglycemia can be discharged, if the plasma glucose level is >60 mg/dL following a 6-hour fast. © 2018 by Turkish Pediatric Association.
Comparing the Complications of Ultrasound-Guided Versus Peripherally Inserted Central
(2016) Ecevit, A.; Ince, D. Anuk; Hanta, D.; Kurt, A.; Harman, A.; Ozkiraz, S.; Gulcan, H.; Tarcan, A.; 0000-0002-2232-8117; 0000-0002-4369-2110; 0000-0002-7386-7110; AAJ-4616-2021; I-6746-2016; K-9824-2013
The Comparison of Neonatal Morbidities in Twin and Singleton Late Preterm Infants
(2016) Ince, D. Anuk; Turan, O.; Cigri, E.; Tekindal, M. A.; Yanik, F.; Ecevit, A.; 0000-0002-4369-2110; 0000-0002-7707-1881; 0000-0002-4060-7048; 0000-0002-2232-8117; I-6746-2016; AAJ-2333-2021; U-9270-2018; AAJ-4616-2021
Continuous Veno Venous Hemodiafiltration in Infants: One Center Experience
(2016) Avci, B.; Gulleroglu, K.; Kantar, A.; Ecevit, A.; Baskin, E.; 0000-0003-1434-3824; 0000-0002-5375-379X; 0000-0002-2232-8117; 0000-0003-1434-3824; 0000-0003-4361-8508; F-3294-2013; GYU-5220-2022; AAJ-4616-2021; AAJ-8833-2021; B-5785-2018
Maternal, Fetal and Placental Factors Associated with Chronic Villitis
(2017) Ayva, E. S.; Aydin, A. T.; Ozkalkan, B.; Gurkan, D.; Abatas, P.; Akcay, P.; Gulumser, C.; Ecevit, A.; Tunca, M. Z.; 0000-0002-2280-8778; 0000-0002-2232-8117; AAK-1967-2021; AAJ-4616-2021
Neonatal Hyperglycemia, which threshold value, diagnostic approach and treatment?: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report
(2018) Gökşen Şimşek, D.; Ecevit, A.; Hatipoğlu, N.; Çoban, A.; Arısoy, A.E.; Baş, F.; Mutlu, G.Y.; Bideci, A.; Özek, E.; 0000-0002-2232-8117; 31236036; AAJ-4616-2021
Hyperglycemia has become an important risk factor for mortality and morbidity in the neonatal period, especially with increased survival rates of very low birth weight babies. Hyperglycemia in the neonatal period develops as a result of various mechanisms including iatrogenic causes, inability to supress hepatic glucose production, insulin resistance or glucose intolerance, specifically in preterm babies. Initiation of parenteral or enteral feeding in the early period in preterm babies increases insulin production and sensitivity. The plasma glucose is targeted to be kept between 70 and 150 mg/dL in the newborn baby. While a blood glucose value above 150 mg/dL is defined as hyperglycemia, blood glucose values measured with an interval of 4 hours of >180-200 mg/dL and +2 glucosuria require treatment. Although glucose infusion rate is reduced in treatment, use of insulin is recommended, if two blood glucose values measured with an interval of 4 hours are >250 mg/dL and glucosuria is present in two separate urine samples. © 2018 by Turkish Pediatric Association.
Turkish neonatal society guideline on the neonatal pain and its management
(2018) Yiğit, Ş.; Ecevit, A.; Altun Köroğlu, Ö.; 0000-0002-2232-8117; 31236029; AAJ-4616-2021
Pain control is an important ethical issue to be considered and constitutes the basis of treatment in premature and term newborns. The inadequacy of pain control in these infants in neonatal intensive care units leads to neurodevelopmental and behavioral problems in the long term. For this reason, it is extremely important to raise awareness of the presence of pain in newborn infants, to reduce invasive procedures applied to infants as much as possible, and to minimize pain with non-pharmacologic or pharmacologic treatments when it is inevitable. © Copyright 2018 by Turkish Pediatric Association.